Literature DB >> 310270

Penetration of atenolol in the rabbit eye.

F E Ros, H C Innemee, P A van Zwieten.   

Abstract

The ocular penetration of topically applied [14C]-atenolol in the rabbit was determined by means of liquid scintillation counting. Only one eye was treated, the fellow eye serving as a control. Blood plasma levels were measured as well. The absolute amount of atenolol which penetrated the eye was very low, but a relatively high concentration was achieved in the tissues of the nictitating membrane. We could only detect an increase in the amount of atenolol with time in the aqueous humor. In all other ocular tissues, including iris and ciliary body, the atenolol level remained constant with time. Hardly any atenolol could be detected in the untreated eye and none in the blood plasma. These findings suggest that the ocular penetration of atenolol administered as an eye drop is very poor. Ocular penetration, therefore, hardly seems to play a part in the antiglaucomatous effect of atenolol.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 310270     DOI: 10.1007/bf00419378

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  12 in total

1.  Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker.

Authors:  M J Elliot; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

Review 2.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

3.  The pharmacology of atenolol.

Authors:  A M Barrett
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

4.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

5.  Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose.

Authors:  M J Macdonald; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1976-11       Impact factor: 4.638

6.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

7.  Timolol, dose response and duration of action.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

8.  Comparison of ocular hypotensive effects of acetazolamide and atenolol.

Authors:  M J Macdonald; S M Gore; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

9.  Effect of topical atenolol on intraocular pressure.

Authors:  K Wettrell; M Pandolfi
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

10.  Atenolol eye drops in glaucoma: a double-masked, controlled study.

Authors:  C I Phillips; S M Gore; M J Macdonald; P M Cullen
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

View more
  4 in total

1.  Penetration of timolol eye drops into human aqueous humour: the first hour.

Authors:  C I Phillips; R S Bartholomew; A M Levy; J Grove; R Vogel
Journal:  Br J Ophthalmol       Date:  1985-03       Impact factor: 4.638

2.  Penetration of timolol eye drops into human aqueous humour.

Authors:  C I Phillips; R S Bartholomew; G Kazi; C J Schmitt; R Vogel
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

3.  Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation.

Authors:  C Schmitt; V J Lotti; J C Le Douarec
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

4.  Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.

Authors:  F E Ros; H C Innemee; P A van Zwieten
Journal:  Doc Ophthalmol       Date:  1980-04-15       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.